Tenaya Therapeutics (TNYA) Retained Earnings (2020 - 2026)
Tenaya Therapeutics' (TNYA) quarterly Retained Earnings came in at -$624.3 million in Q1 2026, down 15.34% year-on-year from -$737.4 million in Q1 2025, and down 3.19% quarter-over-quarter from -$605.0 million in Q4 2025.
Tenaya Therapeutics (TNYA) Retained Earnings (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' Retained Earnings history runs 7 years deep, the most recent figure standing at -$624.3 million for Q1 2026.
- On a quarterly basis, Retained Earnings fell 15.34% year-over-year to -$624.3 million in Q1 2026; TTM through Mar 2026 was -$624.3 million, a 15.34% decrease from a year earlier, with the FY2025 full-year figure at -$605.0 million, down 17.61% from the prior year.
- Retained Earnings declined to -$624.3 million in Q1 2026 per TNYA's latest filing, from -$605.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $603.1 million in Q3 2024 and bottomed at -$624.3 million in Q1 2026.
- The 5-year median for Retained Earnings is -$186.6 million (2022), against an average of -$101.3 million.
- Biggest YoY gain for Retained Earnings was 231170.11% in 2024; the steepest drop was 485193.4% in 2024.
- Year by year, Retained Earnings stood at -$378000.0 in 2022, then surged by 71.96% to -$106000.0 in 2023, then sank by 485193.4% to -$514.4 million in 2024, then retreated by 17.61% to -$605.0 million in 2025, then retreated by 3.19% to -$624.3 million in 2026.
- Per Business Quant, the three latest TNYA Retained Earnings figures stand at -$624.3 million (Q1 2026), -$605.0 million (Q4 2025), and -$584.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Tenaya Therapeutics | 167.00 Mn | 167.00 Mn | - | -624.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -624.28 Mn |
| Dec 31, 2025 | -605.01 Mn |
| Sep 30, 2025 | -584.80 Mn |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -541.28 Mn |
| Dec 31, 2024 | -514.41 Mn |
| Sep 30, 2024 | 603.09 Mn |
| Jun 30, 2024 | 599.00 Mn |
| Mar 31, 2024 | 593.80 Mn |
| Dec 31, 2023 | -106,000.00 |
| Sep 30, 2023 | -261,000.00 |
| Jun 30, 2023 | -344.20 Mn |
| Mar 31, 2023 | -310.90 Mn |
| Dec 31, 2022 | -378,000.00 |
| Sep 30, 2022 | -245.68 Mn |
| Jun 30, 2022 | 439.59 Mn |
| Mar 31, 2022 | -186.59 Mn |
| Dec 31, 2021 | -141,000.00 |
| Sep 30, 2021 | 433.11 Mn |
| Jun 30, 2021 | -111.10 Mn |